Do medical devices need FDA registration?

Medical devices are not registered with the FDA. Establishments must be registered and devices must be listed with the FDA.

What is 510(k) clearance?

510(k) clearance is a premarket submission demonstrating that a medical device is substantially equivalent to a legally marketed device.

Who needs a US Agent?

Foreign manufacturers must appoint a US Agent to communicate with the FDA and assist with inspections.

How long does FDA approval take?

Timelines vary: 510(k) takes around 3–6 months, while PMA can take 1–3 years depending on the device.

USA Medical Device Registration

Overview

Bringing a medical device to market in the USA involves navigating a complex regulatory landscape overseen by the Food and Drug Administration (FDA). The FDA ensures that medical devices are safe, effective, and compliant before they are commercially distributed.

Unlike many countries, the U.S. system focuses on:

Establishment Registration
Device Listing
Premarket Authorization (if required)

Regulatory Authority

The FDA regulates:

Medical Devices
IVDs
Pharmaceuticals
Biologics

👉 Official Website: https://www.fda.gov/

Key Steps for FDA Medical Device Compliance

Medical Device Classification

Devices are classified based on risk:

Class I – Low risk (often exempt)
Class II – Moderate risk (requires 510(k))
Class III – High risk (requires PMA)

Establishment Registration & Device Listing

All manufacturers, importers, and distributors must register their establishments annually
Devices must be listed with the FDA

📅 Renewal period:

October 1 – December 31 (every year)

📌 Regulation:

21 CFR Part 807

US Agent Requirement (For Foreign Manufacturers)

Foreign manufacturers must appoint a:

👉 US Agent

Responsibilities:

Communication with FDA
Inspection coordination
Emergency contact

Premarket Pathways

✔ 510(k) Premarket Notification

Demonstrate substantial equivalence
Timeline: 90–180 days

✔ De Novo Classification

For novel low/moderate risk devices
Timeline: 6–12 months

✔ PMA (Premarket Approval)

Required for Class III devices
Timeline: 1–3 years

✔ Other pathways:

IDE (Investigational Device Exemption)
HDE (Humanitarian Device Exemption)

Link for Regulatory Authority

https://www.fda.gov/

Local Regulation

FDA device regulation

Classification of Medical Devices

Class I, II, III

Listing or Registration Requirements

To be marketed in the United States, medical device companies must comply with requirements set by the U.S. Food and Drug Administration (FDA).
Medical devices are not registered with the FDA. Instead:
- Establishments must be registered
- Devices must be listed
All applicable establishments involved in the manufacture, preparation, propagation, compounding, assembly, or processing of medical devices must register with the FDA under 21 CFR Part 807.
These include:
- Manufacturers
- Contract manufacturers
- Specification developers
- Repackagers/relabelers
- Importers
Establishments are subject to FDA inspections to ensure compliance with Quality System Regulation (21 CFR Part 820). Registration must be renewed annually between October 1 and December 31.
Class I
Class I medical devices are considered low-risk devices. Many Class I devices are exempt from 510(k) premarket notification.
Requirements include:
- Compliance with General Controls
- Implementation of a QMS compliant with 21 CFR Part 820
- Proper labeling in accordance with FDA regulations
Clinical studies are generally not required for Class I devices.
Class II
Class II medical devices are moderate-risk devices. Most Class II devices require a 510(k) Premarket Notification submission to demonstrate substantial equivalence to a legally marketed predicate device.
Requirements include:
- Submission of 510(k) and payment of applicable FDA fees
- Compliance with 21 CFR Part 820 (QMS)
- Performance testing and, in some cases, clinical data
The FDA does not issue a certificate but provides a 510(k) clearance letter, which is publicly available.
Class III
Class III medical devices are high-risk devices that support or sustain human life or present potential high risk. These devices require Premarket Approval (PMA).
Requirements include:
- Implementation of a QMS compliant with 21 CFR Part 820
- Submission of a PMA application
- Provision of valid scientific evidence, including clinical data (mandatory in most cases)
- Payment of applicable FDA fees
PMA approval is required before the device can be marketed in the United States.

Documents Required for USA Medical Device Registration

To market medical devices in the United States, companies must comply with requirements set by the U.S. Food and Drug Administration (FDA). The documentation required depends on the device classification and applicable regulatory pathway (e.g., 510(k), De Novo, PMA).
General Documentation Requirements
- Device Description and Product Specifications
- Intended Use / Indications for Use
- Device Classification and Product Code
- Labeling (in compliance with 21 CFR Part 801)
- Unique Device Identification (UDI) information (as applicable)
- Quality Management System (QMS) documentation (aligned with 21 CFR Part 820 / evolving QMS requirements)
- Risk Management documentation (as per ISO 14971 principles)
For Establishment Registration & Device Listing
- Establishment details (manufacturer, importer, specification developer, etc.)
- US Agent details (for foreign manufacturers)
- Device listing information (proprietary name, classification, product code)
For 510(k) Premarket Notification (if applicable)
- Substantial Equivalence Comparison to a predicate device
- Predicate Device Details
- Performance Testing (bench, biocompatibility, electrical safety, software validation, etc.)
- Risk Analysis
- Sterilization and Shelf-life validation (if applicable)
- Clinical data (if required based on device type)
For De Novo Submission (if applicable)
- Device Description and Novelty Justification
- Risk-benefit analysis
- Performance and safety data
- Clinical evidence (if required)

Registration Timeline

The approval times vary depending on the device classification:

Class I: Few weeks (many Class I devices are exempt from premarket submission)
Class II: 3–6 months (typical timeline for 510(k) clearance; may vary depending on FDA review and additional information requests)
Class III: 1–3 years (PMA approval process involving extensive scientific and clinical review)

License Validity

Device registration: unlimited if there are no substantial changes to the device.

Establishment Registration and Device Listing: annual renewal (from October 1st to December 31st).

Special Labelling Requirements

The FDA does not generally pre-approve labeling as part of establishment registration or device listing. However, labeling is reviewed during applicable premarket submissions (such as 510(k) or PMA) to ensure compliance with regulatory requirements.

Additional Comments

In compliance with 21 CFR 801.20, all medical devices marketed in the United States must bear an UDI (Unique Device Identification) code. The UDI system was implemented as follows:

Placement of the UDI on device labels and packaging
Submission of device identification information to the Global Unique Device Identification Database (GUDID)
Maintenance of accurate and up-to-date UDI data

Medical Device Reporting (MDR)

The U.S. Food and Drug Administration (FDA) receives a large number of medical device reports annually, including reports of suspected deaths, serious injuries, and device malfunctions. Medical Device Reporting (MDR) is a post-market surveillance system used to monitor device performance, detect potential safety issues, and support benefit-risk assessments.

Mandatory reporters are required to submit reports for adverse events and product problems. These include manufacturers, importers, and device user facilities. In addition, voluntary reports from healthcare professionals, patients, caregivers, and consumers provide valuable information that contributes to patient safety.

The FDA reviews MDR submissions by evaluating the information provided, including any follow-up or supplemental reports. However, MDR data has certain limitations, such as under-reporting, incomplete or inaccurate information, and the inability to definitively establish causality in all cases.

Post-Market Surveillance

Section 522 of the Federal Food, Drug, and Cosmetic (FD&C) Act allows the U.S. Food and Drug Administration (FDA) to require manufacturers to conduct post-market surveillance for certain Class II or Class III medical devices.

This requirement involves the systematic collection, analysis, and interpretation of data to address specific public health questions related to the safety and effectiveness of a device. Post-market surveillance under Section 522 helps ensure that devices continue to perform as intended once they are in widespread clinical use.